1. Home
  2. Send a question to our expert about Post-autorisatie surveillance van COVID-19 vaccins

Send a question to our expert about Post-autorisatie surveillance van COVID-19 vaccins

Joris Van Loenhout
Scientist

How do you want to be contacted ?

Contacts

Epidemiologie van infectieziekten

Zorginfecties en antibioticaresistentie

Direct contact with an expert

Peergereviewde publicaties

Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.
Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study
Conceptual causal framework to assess the effect of SARS-CoV-2 variants on COVID-19 disease severity among hospitalized patients
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study.

Evenementen

In de media

Thematisch rapport | Surveillance van de COVID-19-vaccinatie in Belgische woonzorgcentra
Percentage gezondheidswerkers met antistoffen tegen coronavirus stijgt tot 64%
Belgen debatteren over COVID-19 vaccinatie
Aantal bloeddonoren en gezondheidswerkers met antistoffen tegen coronavirus stijgt

Andere publicaties

Is equitable priority vaccination of the vulnerable feasible in a real-world context? The case of Belgium
Estimated number of COVID-19 deaths averted by vaccination in Belgium
Draft implementation plan for a linkage tool
An interdisciplinary approach: Exploring the five dimensions of the tools deployed by EUVABECO
Surveillance van de COVID-19 vaccinatie in Belgische woonzorgcentra. Resultaten tot 24 maart 2021.

Andere informatiebronnen

QR code

QR code for this page URL